hero image
Dr. Mine Durusu-Tanriover - International Federation on Ageing. Ankara, , TR

Dr. Mine Durusu-Tanriover Dr. Mine Durusu-Tanriover

Professor of Internal Medicine | Hacettepe University

Ankara, TURKEY

Prof Mine Durusu Tanriover works closely with regional and global scientific community on adult vaccination, influenza and COVID-19.

Spotlight

Media

Publications:

Documents:

Photos:

loading image loading image loading image loading image loading image

Audio/Podcasts:

Social

Biography

She graduated from Hacettepe University Faculty of Medicine in 2000 and finished her residency training in internal medicine in 2005 in the same university. She has been serving as the consultant of the Acute Care Unit for several years, mainly admitting patients from the emergency department with acute decompensation of chronic diseases; lower respiratory tract infections, organ failure and acute, undiagnosed conditions. Dr. Mine Durusu Tanriover worked as the Co-Chief of Hacettepe University Oncology Hospital and the Quality Coordinator of Hacettepe University Hospitals, a Joint Commission International accredited, 1200-bed academic medical center between 2016-2020. Her research area mainly consists of adult vaccination, influenza, quality improvement and patient safety. She has been involved in the Global Influenza Hospital Surveillance Network project as an investigator and site coordinator since 2012 and participated as a subinvestigator in the phase 3 clinical trials of COVID-19 vaccines available in Turkey. Recently, she has been appointed as the primary investigator of the phase 3 clinical trial of TURKOVAC, an inactivated COVID-19 vaccine. She is the author of more than 50 peer-reviewed articles. Representing the Turkish Society of Internal Medicine, she is a member of the National Adult Immunization Guideline Task Force and Medical Specialty Council Curriculum Preparation Task Force. She is the founder and the first chair of the Young Internists Working Group and honorary fellow of the European Federation of Internal Medicine (EFIM). She is a member of the Quality and Professional Issues and the Adult Vaccination (ADVICE) Working Groups of EFIM. Dr. Durusu Tanriover is currently the Secretary of the Middle East, Eurasia and Africa Influenza Stakeholders Network and the coordinator of the VACCiMENA-HCP project. She believes that we are what we eat and inhale, and a healthy life begins with healthy food and being a part of the nature. Her main area of interest outside her academic activities is farming and spending time in her edible balcony garden. She is married with two children.

Areas of Expertise (8)

Acute Care

Quality Improvement

Vaccines 4 Life Program

Influenza

Vaccination

Adult Vaccination

Patient Safety

COVID19 Vaccines

Education (2)

Hacettepe University: Specialty in Medicine, Internal Medicine 2005

Hacettepe University: MD, Medicine 2000

Affiliations (9)

  • Hacettepe University Hospital : Medical Profession Education Committee Member
  • Hacettepe University Hospital : Patient Safety Committee Member
  • Professor of Internal Medicine, Hacettepe University Faculty of Medicine
  • Co-director, Hacettepe University Oncology Hospital
  • Quality Coordinator, Hacettepe University Hospitals
  • Board Member, Hacettepe University Vaccine Institute
  • Member, European Federation of Internal Medicine, Professional Issues and Quality of Care Working Group
  • Member, European Federation of Internal Medicine, Adult Vaccination Campaign in Europe Working Group
  • Secretary, Middle East, Eurasia And Africa Influenza Stakeholders Network

Languages (2)

  • English
  • Turkish

Event Appearances (3)

Adult Vaccination in Europe

Prague European Days of Internal Medicine  Prague, Czech Republic

Supporting Healthy Ageing Through Vaccination in At-Risk Groups

14th Global Conference on Ageing  Toronto, Canada

Precongress Course: Quality of care, patient safety and doctor-patient communication

18th European Congress of Internal Medicine  Lisbon, Portugal

Sample Talks (5)

Adult Vaccination in Europe

Prague European Days of Internal Medicine, Prague, 1-2 December, 2016

Supporting Healthy Ageing Through Vaccination in At-Risk Groups

14th Global Conference on Ageing, Toronto, Canada, 8-10 August, 2018

Quality of care, patient safety and doctor-patient communication

18th European Congress of Internal Medicine, 29-31 August, 2019, Lisbon, Portugal

Inactivated COVID-19 Vaccine

19th European Congress of Internal Medicine, 18-20 March 2021, Virtual Congress

Are you in a priority group?

Middle East, Eurasia And Africa Influenza Stakeholders Network (ME’NA-ISN) Congress, 22-24 January 2021, Virtual Congress

Featured Articles (14)

The Working Group on Professional Issues and Quality of Care, European Federation of Internal Medicine (EFIM). Hospital ambulatory medicine: A leading strategy for Internal Medicine in Europe

European Journal of Internal Medicine

2018 Addressing the current collision course between growing healthcare demands, rising costs and limited resources is an extremely complex challenge for most healthcare systems worldwide. Given the consensus that this critical reality is unsustainable from staff, consumer, and financial perspectives, our aim was to describe the official position and approach of the Working Group on Professional Issues and Quality of Care of the European Federation of Internal Medicine (EFIM), for encouraging internists to lead a thorough reengineering of hospital operational procedures by the implementation of innovative hospital ambulatory care strategies.

view more

Poor outcomes among elderly patients hospitalized for influenza-like illness

Curr. Med. Res. Opin.

2017 Global Influenza Hospital Surveillance Network is a worldwide initiative that aims to document the burden of influenza infections among acute admissions and vaccine effectiveness in particular countries.

view more

Vaccinating healthcare workers: Level of implementation, barriers and proposal for evidence-based policies in Turkey

Hum. Vaccin. Immunother.

2017 The role of healthcare workers in life-long vaccination is very important in the means of 2 sided infection, rising patient awareness and being a role model for the patients. Numerous organizations publish guidelines for vaccination of HCWs, while healthcare facilities develop vaccination policies according to the accreditation standards. Nevertheless, vaccination rates among HCWs are far below targets.

view more

Perceptions and Attitudes of Patients About Adult Vaccination and Their Vaccination Status: Still a Long Way to Go?

Med. Sci. Monit.

2017 Immunization is one of the most effective public health measures to prevent disease, but vaccination rates in adult populations still remain below the targets. Patient and physician attitudes about vaccination are important for adult vaccination. In this study, we aimed to determine patient attitudes and perceptions about vaccination and the vaccination coverage rates of adult patients in a university hospital in Turkey.

view more

ADVICE for a healthier life: Adult Vaccination Campaign in Europe

Eur. J. Intern. Med.

2016 Immunization is one of the most effective public health measures to prevent disease. Despite relatively good vaccination rates in childhood in many parts of the world, vaccines to prevent diseases are underused in the adult population and adult vaccination rates are still far below the target.

view more

Severe measles pneumonia in adults with respiratory failure: role of ribavirin and high dose vitamin A

Clin. Respir. J.

2016 Although measles is usually considered a benign viral disease of childhood, adults may be affected at any age and may experience severe respiratory or neurologic consequences. We present three adult cases (one of whom was pregnant) admitted to our University Hospital who were diagnosed to have measles and who had uncommon clinical features such as hepatitis and hyponatremia.

view more

Influenza epidemiology and influenza vaccine effectiveness during the 2014–2015 season: annual report from the Global Influenza Hospital Surveillance Network

BMC Public Health

2016 The Global Influenza Hospital Surveillance Network (GIHSN) has established a prospective, active surveillance, hospital-based epidemiological study to collect epidemiological and virological data for the Northern and Southern Hemispheres over several consecutive seasons.

view more

Clinical trial of CoronaVac

The Lancet

Dr. Mine Durusu-Tanriover

2021-07-08

Background CoronaVac, an inactivated whole-virion SARS-CoV-2 vaccine, has been shown to be well tolerated with a good safety profile in individuals aged 18 years and older in phase 1/2 trials, and provided a good humoral response against SARS-CoV-2. We present the interim efficacy and safety results of a phase 3 clinical trial of CoronaVac in Turkey.

view more

Influenza epidemiology and influenza vaccine effectiveness during the 2015–2016 season: results from the Global Influenza Hospital Surveillance Network

The National Center for Biotechnology Information

Dr. Mine Durusu-Tanriover

Background: The Global Influenza Hospital Surveillance Network is an international platform whose primary objective is to study severe cases of influenza requiring hospitalization. Methods: During the 2015–2016 influenza season, 11 sites in the Global Influenza Hospital Surveillance Network in nine countries (Russian Federation, Czech Republic, Turkey, France, China, Spain, Mexico, India, and Brazil) participated in a prospective, active-surveillance, hospital-based epidemiological study. Influenza infection was confirmed by reverse transcription-polymerase chain reaction. Influenza vaccine effectiveness (IVE) against laboratory-confirmed influenza was estimated using a test-negative approach.

view more

Addressing Influenza Vaccination in MENA Region during the COVID-19 Pandemic: Decreasing the Effects of the Collision

The National Center for Biotechnology Information

Salah T. Al Awaidy, Oğuz Abdullah Uyaroğlu , Chadia Wannous and Mine Durusu Tanriover

2020-11-01

The Northern Hemisphere,a including the Middle East and North Africa (MENA) region, is anxiously waiting for the influenza season as it is expected to coincide with the second peak or wave of the novel coronavirus disease 2019 (COVID-19) pandemic causing fear of a ‘twindemic’, where two epidemics happen at the same time. Influenza cases abruptly declined as a result of the COVID-19 mitigation measures, such as hand hygiene, mask-wearing, and social distancing, as well as missed diagnoses due to sick people avoiding healthcare institutions early in the spring.

view more

Cost Utility of Switching From Trivalent to Quadrivalent Influenza Vaccine in Turkey

PubMed

Amine Amiche, Mine Durusu Tanriover, Lucile Bellier, Baris Ugur, Levent Akin

2021-01-19

Objectives: Trivalent influenza vaccines (TIVs) are widely used but protect against only 1 of the 2 co-circulating influenza B virus lineages. Quadrivalent influenza vaccines (QIVs) include a B strain from each lineage to overcome mismatches. The main objective of this study was to determine the cost-utility and budget impact of switching from vaccination with TIV to QIV in the population recommended for influenza vaccination in Turkey.

view more

Low seroprevalance of diphtheria, tetanus and pertussis in ambulatory adult patients: the need for lifelong vaccination

European Journal of Internal Medicine

Mine Durusu Tanriover, Canan Soyler, Sibel Ascioglu,Mustafa Cankurtaran,Serhat Unal

2014-05-07

Highlights - Diphtheria, tetanus, pertussis and measles can cause severe disease in adults. - We studied the seroprevalence rates in a Turkish cohort of ambulatory adults. - More than half of the patients had no protection for diphtheria and tetanus. - Only 10% of the patients had protection for pertussis. - The concept of lifelong vaccination should be implemented.

view more

30-day readmission rate of COVID-19 patients discharged from a tertiary care university hospital in Turkey; an observational, single-center study

The National Center for Biotechnology Information

Oğuz Abdullah UYAROĞLU1 (M.D, Assistant Professor), Nursel Çalık BAŞARAN1 (M.D, Assistant Professor), Lale ÖZIŞIK1 (M.D, Associate Professor), Gülçin Telli Dizman3 (M.D, Assistant Professor), İmdat Eroğlu2 (M.D), Taha Koray ŞAHİN 2 (M.D), Zahit Taş 3 (M.D), Ahmet Çağkan İNKAYA3 (M.D, Associate Professor), Mine Durusu TANRIOVER1 (M.D, Professor), Gökhan Metan3 (M.D, Professor), Gülay Sain GÜVEN1 (M.D, Professor), Serhat ÜNAL3 (M.D, Professor)

Background: The 30-day readmission rate is an important indicator of patient safety and hospital’s quality performance. In this study, we aimed to find out the 30-day readmission rate of mild and moderate severity COVID-19 patients discharged from a tertiary care university hospital and to demonstrate the possible factors associated with readmission.

view more

ADVICE for a healthier life: Adult Vaccination Campaign in Europe

European Journal of Internal Medicine

Lale Ozisik, Mine Durusu Tanriover, Shirley Rigby, Serhat Unal

2016-09-01

Highlights - Adults and elderly do need vaccines within a lifelong immunization schedule. - Communicable diseases are on the rise with aging population, globalization and immunity gaps. - Data for adult vaccination rates in Europe is incomplete. There are no targets except for influenza. - There is a lack of international consensus on adult vaccination guidelines on a European basis. - ‘ADVICE’ is Europe wide initiative of EFIM to raise awareness of adult vaccination.

view more